In obese patients with NAFLD who underwent subtotal gastrectomy, a higher protein expression of liver PPAR-γ has been shown, which may reinforce the lipogenic actions associated with SREBP1 upregulation. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.